Researchers observe good blood-pressure lowering at six months.
Systolic blood pressure of 160 mm Hg or higher raised death-censored graft loss risk twofold.
Patients experienced robust declines in systolic and diastolic pressure after receiving intrathecal clonidine.
Even blood pressure not considered hypertensive may reflect latent risk for adverse outcomes.
In a small study, spironolactone decreased blood pressure with no significant rise in potassium.
Adding other seasonings to food could diminish this preference, new findings suggest.
Data show sustained blood pressure reductions two years after the procedure.
Blood pressure increased in hypertensive patients who took calls before measurements were obtained.
SWL is an independent risk factor for hypertension in patients without CKD.
Risk is greatest in patients with a lower body mass index and younger age.
Canadian study of more than one million health records reveals a twofold increased risk.
Filipinos had the highest rates, followed by Japanese, study found.
Meta-analysis also shows significantly prolonged QT/QTc following consumption.
It is associated with an increased risk of cardiovascular events and death, hypertension, and diabetes.
Use of either drug is associated with similar incidences of adverse cardiovascular events or death.
Oral regimen for three months found to be effective, but no result seen on diastolic readings
Clinicians should adopt systematic screening for LVH when assessing renal risk in hypertensive patients.
Hemodialysis patients who use of the medications are less tolerant of ultrafiltration
The condition was found in nearly 32% of hemodialysis patients, compared with only 8% and 5% of peritoneal dialysis and kidney transplant patients.
Kidney cancer patients with both hypertension and diabetes are twice as likely to undergo nephron-sparing surgery as those with neither condition.
More patients achieving ABC goals, but can be further improved, especially for minorities
Likelihood of end-stage renal disease is increased 14-fold among women with hypertensive disorders in pregnancy.
Risk up with use of diuretic and ACE inhibitor or angiotensin receptor blocker, plus NSAID.
A 10-mm increment in SBP was associated with a 24% increased stroke risk for blacks compared with an 8% increase among whites.
Genetic variant in AGT2R in mothers, fathers, neonates raises risk in mothers with high BMI
Intensive lipid lowering with atorvastatin reduced the risk cardiovascular events in patients with treatment-resistant hypertension.
Twenty-four hour ambulatory blood pressure predicted more cardiovascular endpoints.
In a small study, a multi-electrode system provided a rapid and sustained treatment effect.
Values above and below 120-140 mm Hg in hypertensive patients increase mortality risk.
More than 50 percent of those donors with hypertension are untreated